OccuRx

Melbourne, Australia

OccuRx is a biopharmaceutical company that focuses on the development of innovative therapeutic strategies.

$14.5M raised

Sep 2022

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has OccuRx raised?

OccuRx has raised $14.5M in total funding. The most recent round was Series B. The last funding was announced in September 2022.

Who are OccuRx's investors?

OccuRx's investors include Brandon Capital, Uniseed, Stoic VC, Brandon BioCatalyst, Medical Research Commercialisation Fund (MRCF).

Where is OccuRx headquartered?

OccuRx is headquartered in Melbourne, Australia.

What does OccuRx do?

OccuRx is a biopharmaceutical company that focuses on the development of innovative therapeutic strategies.

What stage is OccuRx at?

OccuRx is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 6, 2022.

MLA

"OccuRx — Funding & Investors." VCBacked, September 6, 2022, https://www.vcbacked.co/company/occurx. Accessed July 1, 2026.

APA

VCBacked. (2022). OccuRx — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/occurx

Wikipedia (cite web)

{{cite web |title=OccuRx — Funding & Investors |url=https://www.vcbacked.co/company/occurx |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 6, 2022.